Transferrin-ricin A chain toxin limits the development of experimental proliferative vitreoretinopathy

Experimental Eye Research

Volumn 62, Issue 6, 1996, Pages 689-696

  Handa, James T ^a   Keithahn, Mari Ann ^a   Jaffe, Glenn J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

antiproliferative effects; proliferative vitreoretinopathy; retinal detachment; toxicity; transferrin ricin A chain toxin

Indexed keywords

RICIN A; TOXIN; TRANSFERRIN; TRANSFERRIN RICIN A TOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTRORETINOGRAPHY; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA DETACHMENT; TRANSMISSION ELECTRON MICROSCOPY; VITREORETINOPATHY;

EID: 0029953705     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1996.0079     Document Type: Article

References (17)

1. Baudouin, C., Brignole, F., Fredj-Reygrobellet, D., Negre, F., Bayle, J., Gastraud, P. (1992). Transferrin receptor expression by retinal pigment epithelial cells in proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 33, 2823-9.
2. Blumenkranz, M., Ophir, A., Claflin, A. J., Hajet, A. (1982). Fluorouracil for the treatment of massive periretinal proliferation. Am. J. Ophthalmol. 94, 458-67.
3. Chandler, D., Quansah, F., Hida, T., Machemer, R. (1986). A refined experimental model for proliferative vitreoretinopathy. Graefe's Arch. Clin. Exp. Ophthalmol. 224, 86-91.
4. Glaser, B. and Lemor, M. (1989). Pathobiology of proliferative vitreoretinopathy. In Retina (Ed. Ryan, S.) Pp. 369-400. Mosby: St. Louis.
5. Handa, J., Houston, L. and Jaffe, G. (1993). The antiproliferative effect of a transferrin-toxin on human retinal pigment epithelial cells and rabbit fibroblasts. Invest. Ophthalmol. Vis. Sci. 34, 3419-28.
6. Hatchell, D., McAdoo, T., Sheta, S., King, R. T., 3rd, Bartolome, J. V. (1988). Quantification of cellular proliferation in experimental proliferative vitreoretinopathy. Arch. Ophthalmol. 106, 669-72.
7. Hida, T., Chandler, D. and Sheta, S. (1987). Classification of the stages of proliferative vitreoretinopathy in a refined experimental model in the rabbit eye. Graefe's Arch. Clin. Exp. Ophthalmol. 225, 303-7.
8. Khawly, J., Saloupis, P., Hatchell, D., Machemer, R. (1991). Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. Graefe's Arch. Clin. Exp. Ophthalmol. 229, 464-7.
9. Kuhn, L. (1989). The transferrin receptor: a key function in iron metabolism. Schweiz Med. Wschr. 119, 1319-26.
10. Nao, I. and Honda, Y. (1983). Toxic effect of fluorouracil on the rabbit retina. Am. J. Ophthalmol. 96, 641-3.
11. Rubsamen, P., Davis, P., Hernandez, E., O'Grady, G. E., Cousins, S. W. (1994). Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for sustained release fluorouracil. Arch. Ophthalmol. 112, 407-13.
12. Silicone Study Group. (1992). Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 2. Arch. Ophthalmol 110, 780-92.
13. Silicone Study Group. (1992). Vitrectomy with silicone oil or sulfur hexafluoride gas in eyes with severe proliferative vitreoretinopathy: results of a randomized clinical trial. Silicone Study Report 1. Arch. Ophthalmol. 110, 770-9.
14. Steinhorst, U., Chen, E., Hatchell, D., Samsa, G. P., Saloupis, P. T., Westendorf, J., Machemer, R. (1993). Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 34, 1753-60.
15. Steinhorst, U., Chen, E., Machemer, R., Hatchell, D. L. (1993). N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina. Exp. Eye Res. 56, 489-95.
16. Steinhorst, U., Hatchell, D., Chen, E., Machener, R. (1993). Ocular toxicity of daunomycin: effects of subdivided doses on the rabbit retina after vitreous gas compression. Graefe's Arch. Clin. Exp. Ophthalmol. 231, 591-4.
17. Wiedemann, P., Kirmani, M., Santana, M., Sorgente, N., Ryan, S. J. (1983). Control of experimental massive periretinal proliferation by daunomycin: dose-response relation. Graefe's Arch. Clin. Exp. Ophthalmol. 220, 233-5.